Recommendations of the Brazilian Society of Rheumatology for the induction therapy of ANCA-associated vasculitis

Souza, Alexandre Wagner Silva de; Calich, Ana Luisa; Mariz, Henrique de Ataíde; Ochtrop, Manuella Lima Gomes; Bacchiega, Ana Beatriz Santos; Ferreira, Gilda Aparecida; Rêgo, Jozelia; Perez, Mariana Ortega; Pereira, Rosa Maria Rodrigues; Bernardo, Wanderley Marques; Levy, Roger Abramino.
Rev. bras. reumatol ; 57(supl.2): s484-s496, 2017. tab
Artículo en Inglés | LILACS | ID: biblio-899489

Documentos relacionados

  1. Recommendations of the Brazilian Society of Rheumatology for the induction therapy of ANCA-associated vasculitis.
  2. CanVasc consensus recommendations for the use of avacopan in antineutrophil cytoplasm antibody-associated vasculitis: 2022 addendum.
  3. Efficacy and safety of low- versus high-dose glucocorticoid regimens for induction of remission of anti-neutrophil cytoplasm antibody-associated vasculitis: a systematic review and meta-analysis.
  4. [Treatment response and complications of older patients with ANCA(antineutrophil cytoplasmatic antibody)-associated vasculitis].
  5. Current treatment approach to ANCA-associated vasculitis.
  6. Induction and maintenance of remission with mycophenolate mofetil in ANCA-associated vasculitis: a systematic review and meta-analysis.
  7. Predictors of damage accrual in patients with antineutrophil cytoplasmic antibody-associated vasculitis: A nationwide prospective study.
  8. Association of baseline soluble immune checkpoints with the risk of relapse in PR3-ANCA vasculitis following induction of remission.
  9. Systematic review and meta-analysis for 2023 clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of ANCA-associated vasculitis.
  10. [Cortisone-free rheumatology-Vasculitides].